Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
Elevated serum levels of cystatin C are found to be related to poor outcome and metastatic potential of some malignant disorders. To evaluate the clinical prominence of serum cystatin C in diffuse large B-cell lymphoma (DLBCL), blood samples were obtained from 58 patients at the time of diagnosis an...
Main Authors: | Nada E. Hammouda, Manal A. Salah El-Din, Mamdouh M. El-Shishtawy, Amal M. El-Gayar |
---|---|
Format: | Article |
Language: | English |
Published: |
Österreichische Apotheker-Verlagsgesellschaft m. b. H.
2017-03-01
|
Series: | Scientia Pharmaceutica |
Subjects: | |
Online Access: | http://www.mdpi.com/2218-0532/85/1/9 |
Similar Items
-
Clinicopathological spectrum of Diffuse Large B Cell lymphoma: a study targeting population yet unexplored in Pakistan
by: H. Mahmood, et al.
Published: (2021-09-01) -
Extranodal natural killer T cell lymphoma of the oropharyx: case report
by: Ashraf Saad Abou-Halawa, et al.
Published: (2021-08-01) -
Primary parotid lymphoma from a regional cancer center in South India
by: Lakshmaiah KC, et al.
Published: (2014-08-01) -
When a Goitre is a Thyroid Lymphoma
by: Mariana de Aguiar Gonçalves, et al.
Published: (2018-12-01) -
Primary non-hodgkin′s lymphoma of bone: Experience of a decade
by: Qureshi Asim, et al.
Published: (2010-04-01)